✦ LIBER ✦

Paradoxical under-prescription of lipid-lowering therapy for secondary prevention of coronary heart disease in high-risk subjects

✍ Scribed by J. Perdrix; V. Mooser; R. Darioli

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lipid-lowering therapy for the primary p

✍ Antonio M Gotto Jr 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 147 KB

Resource management in prevention of cor

✍ James Shepherd 📂 Article 📅 2002 🏛 The Lancet 🌐 English ⚖ 61 KB

The use of lipid-lowering therapy for se

✍ Jessica M. Ma; Cynthia A. Jackevicius; Uchenwa Genus; Vladimir Dzavik 📂 Article 📅 2006 🏛 Pulsus Group Inc 🌐 English ⚖ 159 KB

The effect of lipid-lowering therapy on

✍ Vulic, D.; Keric, Lj.; Vulic, B.; Bajic, S.; Pavic, Z. 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 173 KB

Lipid-lowering therapy does not increase

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 135 KB

Sheffield risk and treatment table for c

✍ MichaelA James; A.S Wierzbicki; T.M Reynolds; Roberto Marchioli; Elena Bomba; Gi 📂 Article 📅 1996 🏛 The Lancet 🌐 English ⚖ 651 KB